Patients with high levels of C5AR1 had significantly shorter RFS and OS (p<0.001). They found significantly higher C5AR1 levels in primary NSCLC tumors from patients who developed bone metastases during disease progression compared with those from patients who developed metastases to other non-skeletal sites. The gene discussed is C5AR1; the disease is non-small cell lung carcinoma.